Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials.

چکیده

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) improve cardiometabolic outcomes in type 2 diabetes, but retinal safety remains debated as use expands. We searched Embase, PubMed, Web of Science, and ClinicalTrials.gov through November 15, 2025, for randomized trials reporting diabetic…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• رتینوپاتی دیابتی